Cargando...
NYSE: HCA
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueIngresos Totales | $75.6B+7.1% | $70.6B+8.7% | $65.0B+7.9% | $60.2B+2.5% | $58.8B+14.0% | $51.5B+0.4% | $51.3B+10.0% | $46.7B+7.0% | $43.6B+5.1% | $41.5B |
| Cost of RevenueCosto de Ventas | — | — | — | — | — | — | — | — | — | — |
| Gross ProfitUtilidad Bruta | — | — | — | — | — | — | — | — | — | — |
| Research & DevelopmentInvestigación y Desarrollo | — | — | — | — | — | — | — | — | — | — |
| Selling, General & AdministrativeGastos Generales y Adm. | $548.0M+30.2% | $421.0M+19.3% | $353.0M-6.6% | $378.0M-5.5% | $400.0M-3.8% | $416.0M+12.4% | $370.0M+7.6% | $344.0M-7.8% | $373.0M0.0% | $373.0M |
| Total Operating ExpensesGastos Operativos Totales | $65.8B+5.9% | $62.1B+8.4% | $57.3B+10.9% | $51.7B+5.6% | $48.9B+6.1% | $46.1B+0.0% | $46.1B+11.5% | $41.3B+5.4% | $39.2B+7.0% | $36.7B |
| Operating IncomeUtilidad Operativa | — | — | — | — | — | — | — | — | — | — |
| Other Income/(Expense), NetOtros Ingresos/(Gastos), Neto | — | — | — | — | — | — | — | — | — | — |
| Pretax IncomeUtilidad Antes de Impuestos | $9.8B+15.4% | $8.5B+10.6% | $7.7B-10.2% | $8.6B-12.7% | $9.8B+81.1% | $5.4B+3.5% | $5.2B-1.7% | $5.3B+21.8% | $4.4B-8.9% | $4.8B |
| Tax ProvisionImpuestos | $2.0B+9.9% | $1.9B+15.5% | $1.6B-7.5% | $1.7B-17.3% | $2.1B+102.5% | $1.0B-5.1% | $1.1B+16.2% | $946.0M-42.2% | $1.6B+18.9% | $1.4B |
| Net IncomeUtilidad Neta | $7.8B+16.9% | $6.7B+9.3% | $6.1B-10.9% | $6.8B-11.5% | $7.7B+76.0% | $4.4B+5.8% | $4.1B-5.6% | $4.4B+60.0% | $2.7B-20.1% | $3.4B |
| EBITDA | — | — | — | — | — | — | — | — | — | — |
| Basic EPSUPA Básica | $28.70+28.9% | $22.27+15.7% | $19.25-0.9% | $19.43-9.7% | $21.52+93.9% | $11.10+8.1% | $10.27-5.8% | $10.90+78.1% | $6.12-18.7% | $7.53 |
| Diluted EPSUPA Diluida | $28.33+28.8% | $22.00+16.0% | $18.97-0.9% | $19.15-9.5% | $21.16+93.6% | $10.93+8.5% | $10.07-5.5% | $10.66+79.2% | $5.95-18.5% | $7.30 |